---
cluster_sources:
- '[[note/Platform Questionnaire Direct-Send Verification Call 2025-10-09]]'
- '[[note/Meeting Transcript Validation Audit Report]]'
- '[[note/Meeting Data Validation Audit Report 2026-02-26]]'
- '[[note/Meeting Markdown Validation Audit Report]]'
confidence: medium
created: '2026-04-01'
name: Deployment Verification Relies on Informal Personal Channels Not Structured
  QA
project:
- '[[project/Telia''z AI Clinical Platform]]'
related:
- '[[decision/Deploy Questionnaire Direct-Send to Patients]]'
- '[[constraint/Patient Phone Number Required for Questionnaire Direct-Send]]'
- '[[assumption/Intake Data Entry Quality Supports Automated Patient Workflows]]'
status: draft
supports:
- '[[synthesis/Feature Technical Readiness Outpaces Data Quality and Operational Process
  Readiness]]'
type: synthesis
---

# Deployment Verification Relies on Informal Personal Channels Not Structured QA

## Insight

Feature deployments and data pipeline validations are verified through ad-hoc personal actions rather than a structured QA or release verification process. Rami personally called Shachar to confirm the questionnaire direct-send deployment, discovering a data quality issue (missing patient name) only through this impromptu check. Pipeline validation is performed through repeated manual audit reports rather than automated monitoring. No formal release verification checklist, automated smoke tests, or deployment confirmation workflow exists.

## Evidence

- **Questionnaire Direct-Send Verification Call (2025-10-09)**: Rami made an unplanned phone call to Shachar to verify the deployment was live, asking him to check a specific patient case. The call had intermittent audio drops, yet this was the primary verification mechanism.
- **Data quality issue discovered ad-hoc**: During the same call, Rami noticed a patient's name was missing — this was caught by human observation, not by a system validation.
- **Three identical audit reports**: Meeting pipeline validation was performed manually three separate times, each producing essentially the same findings — no automated monitoring detected the persistent 84.3% ingestion gap.

## Implications

- Critical clinical features go live without formal verification, creating risk of undetected failures affecting patient care workflows
- Data quality issues (like missing patient names) are discovered by chance rather than by systematic validation
- The team's verification capacity does not scale — as more features deploy, personal spot-checks become insufficient
- A lightweight release verification process (automated smoke test or checklist) would catch issues currently relying on Rami's personal attention
- This pattern reinforces the synthesis that feature technical readiness outpaces operational process readiness

## Applicability

Applies to all feature deployments for the Telia'z clinical platform, particularly patient-facing features where data quality directly impacts clinical workflows. Also relevant to data pipeline monitoring where manual audits substitute for automated health checks.

![[learn-synthesis.base#Sources]]
![[learn-synthesis.base#Related]]
